Navigation Links
Depression Pipeline Market H2 2015 Review (87 Companies) Report
Date:3/14/2016

PUNE, India, March 14, 2016 /PRNewswire/ --

RnRMarketResearch.com adds "Depression - Pipeline Review, H2 2015" market research report to its store with comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Depression and special features on late-stage and discontinued projects.

Complete report on H2 2015 pipeline review of Depression with 152 market data tables and 17 figures, spread across 511 pages is available at http://www.rnrmarketresearch.com/depression-pipeline-review-h2-2015-market-report.html   

The report also reviews key players involved in the therapeutic development for Depression and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this Depression Pipeline Review, H2 2015 report include AB Science SA, Acetylon Pharmaceuticals, Inc., Ache Laboratorios Farmaceuticos S/A , Adamed Sp. z o.o., Addex Therapeutics Ltd, Aequus Pharmaceuticals Inc., Alkermes Plc, Allergan Plc, Alvogen Korea, Amorsa Therapeutics Inc., Anavex Life Sciences Corp., Angelini Group, Angita B.V., ANP Technologies, Inc., Ascendis Pharma A/S, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., BioCrea GmbH, Bionomics Limited, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Calico LLC, Cerecor Inc., Clera Inc., Convergence Pharmaceuticals Ltd., D-Pharm Ltd., Delpor, Inc., Domain Therapeutics SA, e-Therapeutics Plc, Eisai Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, GliaCure Inc., H. Lundbeck A/S, Heptares Therapeutics Limited, HolsboerMaschmeyer NeuroChemie GmbH, Hua Medicine Ltd., Hyundai Pharmaceutical Co., Ltd., INSYS Therapeutics, Inc., Intas Pharmaceuticals Ltd., Intra-Cellular Therapies, Inc., Jiangsu Hansoh Pharmaceutical Co., Ltd., Johnson & Johnson, KemPharm, Inc., Lead Discovery Center GmbH, Luye Pharma Group Ltd., M et P Pharma AG, Mapreg S.A.S., Meta-IQ ApS, Methylation Sciences Inc., MI.TO. Technology S.r.L., miCure Therapeutics Ltd., Mitsubishi Tanabe Pharma Corporation, Neuralstem, Inc., Neurocrine Biosciences, Inc., NeuroNascent, Inc., NeurOp, Inc, Newron Pharmaceuticals S.p.A., Nippon Chemiphar Co., Ltd., nLife Therapeutics, S.L., Novartis AG, Omeros Corporation, Otsuka Holdings Co., Ltd., Pfizer Inc., Pherin Pharmaceuticals, Inc., Polleo Pharma Limited, Protagenic Therapeutics Inc., Reviva Pharmaceuticals Inc., Richter Gedeon Nyrt., RTI International, Saniona AB, SK Biopharmaceuticals Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc., Supernus Pharmaceuticals, Inc., Suven Life Sciences Ltd., Taisho Pharmaceutical Holdings Co., Ltd., Takeda Pharmaceutical Company Limited, Tetra Discovery Partners LLC, Teva Pharmaceutical Industries Limited, Trevena, Inc., Turing Pharmaceuticals AG , VistaGen Therapeutics , Inc., Zhejiang Huahai Pharmaceutical Co., Ltd., Zogenix, Inc. and Zysis Limited.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=454724  

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Depression and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities with key players involved in the therapeutics development for Depression and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects, review of the Depression products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Depression pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

Another newly published market research report titled on Stroke - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Stroke and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Stroke Pipeline market research report of 563 pages is available at http://www.rnrmarketresearch.com/stroke-pipeline-review-h2-2015-market-report.html  

Explore more reports on Neurology therapeutics

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com

Connect with Us:

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345


'/>"/>
SOURCE RnR Market Research
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Depression and Autism Reviewed by NeuroPerspective
2. American Psychiatric Association Task Force Report Identifies Potential Value of NeuroRx Active Ingredient for Treatment of Depression
3. Dr. Maurizio Fava, Internationally Renowned Expert in the Field of Depression, Joins VistaGens Clinical and Scientific Advisory Board
4. Iodine Announces Collaboration With Postpartum Progress To Help Find What Works Best For Women With Postpartum Depression
5. NeuroRx Announces First Human Trial Results Targeting Sustained Treatment of Bipolar Depression & Suicidality
6. Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression
7. Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression
8. Northeasterners Are Tougher Than Other Regions, According to Winter Depression Symptom Research from InCrowd
9. Studies Show Respiratory Motion Patient Monitor May be Early Warning System for Respiratory Depression
10. The Impact of Genericization in the Unipolar Depression Market Will be Tempered by the Continued Uptake of Novel Antidepressants and Antipsychotics
11. New MTHFR Gene Test Extends Holistic Pharmacogenomics Approach to Treating Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/10/2017)... Burchfield, DPM, is recognized by Continental Who,s Who as a Pinnacle ... Alabama . Dr. Burchfield serves as a ... 20 years of experience, as well as expertise in the areas ... "The podiatry professional   ... welcome you to his practice," the company,s website states. "We want ...
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
Breaking Medicine Technology:
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... The ... facelift . Dr. Talei has come up with a proprietary technique that he ... and lifts tissues that have dropped. For all ages, patients can expect to look ...
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows , ... society in 11 countries across the Middle East and South Asia to embark on ... knowledge and ideas with the leading minds in their fields. , For the ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... Flood Insurance offerings. With the Federal Emergency Management Agency’s (FEMA) recent update of ... United States. In 2012, the Biggert-Waters Act was enacted to reflect the actual ...
(Date:6/23/2017)... ... 23, 2017 , ... The Katyl Agency, a locally owned ... business owners in and around Lackawanna County, is joining Meals On Wheels of ... , Meals on Wheels of NEPA provides hand-delivered and nutritious meals to seniors ...
(Date:6/23/2017)... ... 2017 , ... Radabaugh & Associates, a locally owned firm ... in North Central West Virginia, is embarking on a cooperative charity drive with ... the region. , The Stepping Stones organization offers a series of personal development ...
Breaking Medicine News(10 mins):